Integrins are very attractive therapeutic targets in oncology. The anti-tumor mechanisms of integrin-targeting drugs have been validated both in vitroand in vivo. Integrin-targeting drugs are ...

Big Money buying in the shares is signaling to take notice. Given the historical gains in share price and strong fundamentals, this stock could be worth a spot in a diversified portfolio.

This highlights the need for novel drug candidates with new mechanisms of action by targeting alternative signaling pathways. While hERG channel is notoriously regarded as an off-target due to ...

We recently compiled a list of the Blackrock's 30 Most Important AI Stocks. In this article, we are going to take a look at where Robinhood Markets, Inc. (NASDAQ:HOOD) stands against the other AI ...

In today’s rapidly evolving digital landscape, data and artificial intelligence (AI) are no longer optional tools—they are essential drivers of innovation, efficiency and competitive advantage ...

part of the TGF-β superfamily, regulates cell proliferation, differentiation, and death. In muscle tissue, Activin interacts with the Activin RII receptor, triggering intracellular signaling ...

Studies by Jeffrey Klomp et al. 6 and Jennifer Klomp et al. 7 refine our understanding of the signaling effects of oncogenic KRAS. The studies suggest that mutant KRAS signals predominantly ...

The primary node molecules in the cell signaling network in cancer tissues are maladjusted and mutated in comparison to normal tissues, which promotes the occurrence and progression of cancer.